肺静脉血流评价小儿先天性心脏病左心室舒张功能

目的探讨肺静脉血流方法评价先天性心脏病(先心病)患儿左心室舒张功能的应用价值.方法 35例患病组于术前1周内及术后1个月应用肺静脉血流频谱评价左室舒张功能并与二尖瓣口血流方法比较,同时与37例正常对照组进行对比研究.患病组据心室负荷分左心型和右心型.结果左心型术前D波增高,S/D与TS/TD比值下降,术后S波D波速度较术前明显降低,S/D比值增加,TS增加,TD减低,TS/TD比值增加.右心型术前S波增高,S/D比值增高,TS/TD比值下降,术后D波速度增加,S/D比值减低,TS/TD比值增加.患病组中71%二尖瓣口血流E/A比值正常,其中92%通过肺静脉血流频谱TS/TD比值异常检测出左室舒张功能异常,56%肺静脉血流频谱S/D比值异常.结论肺静脉血流方法是评价先心病患儿术前左室舒张功能的可靠方法,可鉴别二尖瓣血流E/A比值假性正常.     

静脉血栓的抗磷脂蛋白抗体与抗凝血、纤维蛋白溶解关系

为了探讨静脉血栓的病因病理及其与抗凝血、纤维蛋白溶解的关系 ,对 4 7例静脉血栓 (VT)患者用酶联免疫法检测抗心肌磷脂抗体 (ACA) ,用凝血法测定狼疮抗凝物 (LA)和抗活化蛋白C抗性 (APCR) ,用多聚酶链反应内切酶法鉴定因子VLeiden ,用发色底物法测定抗凝血酶Ⅲ (ATⅢ )、蛋白C(PC)、纤溶酶原 (Plg)、组织纤溶酶原激活物 (tPA)、组织纤溶酶原激活物抑制物 (tPAI)等抗凝血、纤维蛋白溶解活性。结果表明 :VT患者中 3 4 %有ACA和 (或 )LA阳性 ,其中以ACAIgG和LA为主 ;9.5 %的Plg缺乏 ,8.3 %的tPAI升高 (明显高于对照 ,P <0 0 0 5 ) ;ATⅢ、PC、tPA缺乏者依次为 4 .5 %、4 .5 %、2 .8% (与对照无差异性 ,P >0 .0 5 ) ;ATⅢ、PC、Plg联合缺乏者 1例 ;APCR未发现相应的factorVLeiden ;抗磷脂蛋白抗体 (APA)阳性和阴性组之间的各抗凝血和纤维蛋白溶解活性没有明显差异性 ;4例APCR阳性 ,3例ACA和 (或 )LA阳性 ,这 3例血浆和正常血浆混合后 2例APCR并没有完全得到纠正。结论 :抗磷脂蛋白抗体和纤维蛋白溶解异常是VT较多见的相关病理因素 ;LA和 (或 )ACA干扰蛋白C抗凝血途径 ,使之形成获得性APCR ,而此APCR可能是体内导致易栓的病因之一。     

Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind,randomised, prospective,controlled trial

Background Central venous catheters (CVCs) are essential for the intensive care of patients with haematological illness. Catheter-related infections (CRI) are an important problem in modern medicine, which may lead to life-threatening situations, to prolonged hospitalisation and increased cost. In immunocompromised patients suffering from haemato-oncological diseases, CRI is a significant factor for adverse outcome. Several clinical studies have shown that CVCs coated with antiseptics such as chlorhexidine and silver-sulfadiazine (CHSS) reduce the risk of catheter-related bacteraemia. Most studies, however, were performed on intensive care patients not suffering from chemotherapy-induced immunosuppression.Patients and methods A prospective double-blind, randomised, controlled trial was performed to investigate the effectiveness of CHSS-coated catheters in haemato-oncological patients. A total number of 184 catheters (median duration of placement, 11 days) were inserted into 184 patients (male 115, female 69), of which 90 were antiseptically coated. After removal, all catheters were investigated for bacterial growth.Main results Catheters coated with CHSS were effective in reducing the rate of significant bacterial growth on either the tip or subcutaneous segment (26%) compared to control catheters (49%). The incidence of catheter colonisation was also significantly reduced (12% coated vs 33% uncoated). Data obtained show a significant reduction of catheter colonisation in CHSS catheters. There was no significant difference in the incidence of catheter-related bacteraemia (3% coated vs 7% uncoated). However, due to the overall low rate of CRI, we could not observe a significant reduction in the incidence of catheter-related bacteraemia.Conclusion Our data show that the use of CHSS catheters in patients with haematological malignancy reduces the overall risk of catheter colonisation and CRI, although the incidence of catheter-related bacteremia was similar in both groups.     

Clinical outcome of patients with venous thromboembolism and recent major bleeding: findings from a prospective registry (RIETE)

BACKGROUND: Patients who have experienced a recent major bleeding episode are usually excluded from clinical studies of venous thromboembolism (VTE) treatment. Therefore, recommendations based on evidence from clinical trials may not be suitable for these patients. The Registro Informatizado de la Enfermedad TromboEmbolica (RIETE) is a multicenter, observational registry designed to gather and analyze data on VTE treatment practices and clinical outcomes in patients with acute VTE. OBJECTIVES: The aim of this analysis was to study outcomes of patients with VTE who had experienced recent major bleeding (< 30 days prior to VTE diagnosis). METHODS: Patients with objectively confirmed symptomatic acute VTE are consecutively enrolled into the RIETE registry. Patient characteristics, details of antithrombotic therapy, and clinical outcomes at 3 months were recorded. RESULTS: Of 6361 patients enrolled up to January 2004, 170 (2.7%) had experienced recent major bleeding: 69 (40.6%) gastrointestinal tract, 60 (35.3%) intracranial, 41 (24.1%) other. The incidences of major bleeding (4.1%) and recurrent pulmonary embolism (PE) (2.4%) were significantly higher in patients with recent major bleeding. Among them, patients with cancer had an increased incidence of major bleeding [odds ratio (OR) 10.0, 95% confidence interval (CI) 2.3, 50; P < 0.001] and fatal PE (OR 4.1, 95% CI 0.98, 17; P < 0.05). CONCLUSIONS: Patients with VTE and recent major bleeding prior to VTE diagnosis (2.7% of total enrolled patients) had poorer clinical outcomes compared with those who had not experienced recent major bleeding. In patients who had recent major bleeding prior to enrollment, those with cancer had a poorer clinical outcome than those without cancer.     

磨牙开髓新进路临床应用体会

目的 评估磨牙开髓新进路的可靠性,探索其优点.方法 186颗下颌磨牙,120颗上颌磨牙,牙髓病、尖周病、下牙采用近中及远中面开髓,上牙采用颊侧与舌侧面开髓,保留髓室顶进行根管治疗.结果 306颗磨牙,通过新进路开髓扩根,寻找根管口容易,可使入口与各根管连成直线通路,扩根操作方便,经1～9年临床观察,无一例冠折.结论 上下颌磨牙保留髓室顶进行根管治疗,能保留更多的牙体组织,操作方便,疗效可靠,避免牙髓治疗后冠折,较传统的去髓顶根管治疗有明显优点.     

Endovascular coil embolization of a spinal epidural arteriovenous fistula with associated cord compression from an enlarging venous varix

Spinal arteriovenous fistulas (AVFs) completely isolated to the epidural compartment are exceedingly rare. As such, the optimal management of these lesions is poorly defined. The aim of this technical note is to describe our endovascular technique for the occlusion of a purely epidural AVF of the thoracic spine associated with cord compression from an associated enlarging venous varix. A 40-year-old male presented with severe right-sided back pain and anterior thigh numbness after a sports-related back injury six months previously. Spinal magnetic resonance imaging (MRI) showed an enhancing, extradural mass lesion at T12. Spinal angiography revealed an epidural AVF supplied by a radicular branch of the right T12 subcostal artery and draining into the paravertebral lumbar veins, as well as an adjacent 20 × 13 mm² contrast-filling sac, compatible with a dilated venous varix. There was no evidence of intradural venous drainage. We elected to proceed with endovascular treatment of the lesion. At the time of embolization five days later, the venous varix had enlarged to 26 × 16 mm². The T12 epidural AVF was completely occluded with two coils, without residual or recurrent AVF on follow-up angiography one month later. The patient made a full recovery, and complete resolution of the venous varix and cord compression were noted on MRI at three months follow-up. Endovascular coil embolization can be successfully employed for the treatment of appropriately selected spinal epidural AVFs. Cord compression from an enlarging venous varix can be treated concurrently with endovascular occlusion of an associated spinal epidural AVF.     

生理盐水加量冲洗法对化疗患者静脉保护作用的临床观察

目的　探讨加量生理盐水冲洗法对化疗患者的静脉保护作用。方法　采用自身对照方法 ,将每例患者的两臂随机分成对照组和观察组 ,各 48例次。观察组先以生理盐水引路穿刺 ,待确保针头在血管内再推入或输入化疗药物 ,输毕用生理盐水 2 0 ml静推冲洗血管 ,然后以 40～ 6 0滴 /min的速度滴入余量生理盐水。对照组按常规方法静滴。观察疗程中静脉炎发展程度及血管疼痛 ,并进行对比分析。结果　生理盐水加量冲洗法较常规滴注法预防静脉炎效果显著 ,观察组静脉炎发生率为 2 9.1% ,对照组则为 83.3% ,局部血管疼痛观察组低于对照组 (P <0 .0 5 )。结论　加量生理盐水冲洗法对化疗患者的静脉有明显的保护作用 ,特别对长期需要静脉化疗给药的患者可有效降低静脉炎发生率。     

Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation

• Steroids if taken chronically or periprocedurally contribute to delayed wound healing and decreased vascular patency
• Access site complications after diagnostic interventional procedures carry significant morbidity, increased cost, and prolonged hospital stay
• TAVI offers high risk surgical candidates with severe aortic stenosis a significant survival advantage

     

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery

A 42‐year‐old woman with tricuspid atresia who underwent a Fontan surgery (atrio‐pulmonary connection) was admitted to our hospital due to symptomatic ventricular tachycardia (VT). A defibrillation lead was implanted in a distal site of a coronary vein since there was no usual entry to the ventricle. Ventricular pacing was impossible due to the high threshold, however, good sensing was obtained. Three years later, she felt palpitations and a subsequent shock therapy while climbing stairs. The cardioverter data showed that an appropriate cardioversion therapy successfully converted VT to normal rhythm.     

Left Atrial Contribution to Left Ventricular Filling in Patients with Mitral Stenosis: Combined Analysis of Transmitral and Pulmonary Venous Flow Velocities

We recorded transmitral and pulmonary venous flow velocities using transthoracic continuous-wave and transesophageal pulsed Doppler echocardiography, respectively, in 36 patients with mitral stenosis who were in sinus rhythm to investigate the left atrial contribution to left ventricular filling in mitral stenosis. The mitral valve area was determined by transthoracic two-dimensional short-axis echocardiography. Patients were classified as having mild stenosis (± 1.5 cm², n = 17) or moderate stenosis (< 1.5 cm², n = 19). The mean pulmonary capillary wedge pressure and left atrial maximal diameter were significantly larger, and left atrial volume change during atrial contraction was significantly smaller in the moderate group than in the mild group. The percent left atrial contribution to left ventricular filling, estimated from the transmitral flow velocity, the peak atrial systolic velocity, and the percent ratio of left atrial systolic regurgitation to left atrial filling, estimated from the pulmonary venous flow velocity, were significantly lower in the moderate group than in the mild group. The percent left atrial contribution to left ventricular filling, the peak atrial systolic velocity, and the percent ratio of left atrial systolic regurgitation to left atrial filling were positively correlated with the mitral valve area and negatively correlated with the mean pulmonary capillary wedge pressure. These results suggest that the left atrial contribution to left ventricular filling in patients with mitral stenosis in sinus rhythm decreases as the severity of valve stenosis increases, and that analysis of the atrial systolic waves of the transmitral and pulmonary venous flow velocities provides important information for evaluation of left atrial systolic performance in patients with mitral stenosis.